Evolution of Phage Display Technology: From Discovery to Application

Evolution of Phage Display Technology: From Discovery to Application Publisher Pubmed

Rahbarnia L^{1, 2} ; Farajnia S¹ ; Babaei H¹ ; Majidi J³ ; Veisi K⁴ ; Ahmadzadeh V¹ ; Akbari B⁵

Show Affiliations

1. Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
3. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4. Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tabriz, Iran
5. Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, University Of Medical Sciences Tabriz, Tabriz, Iran

Source: Journal of Drug Targeting Published:2017

Abstract

Phage display technology as a selection-based system is an attractive method for evolution of new biological drugs. Unique ability of phage libraries for displaying proteins on bacteriophage surfaces enable them to make a major contribution in diverse fields of researches related to the diagnosis and therapy of diseases. One of the great challenges facing researchers is the modification of phage display technology and the development of new applications. This article reviews the molecular basis of phage display library, and summarizes the novel and specific applications of this technique in the field of biological drugs development including therapeutic antibodies, peptides, vaccines, and catalytic antibodies. © 2016 Informa UK Limited, trading as Taylor & Francis Group.

Related Docs

1. Advances in Phage Display Technology for Drug Discovery, Expert Opinion on Drug Discovery (2015)

2. An Overview on Display Systems (Phage, Bacterial, and Yeast Display) for Production of Anticancer Antibodies; Advantages and Disadvantages, International Journal of Biological Macromolecules (2022)

3. Development of a Novel Human Scfv Against Egfr L2 Domain by Phage Display Technology, Current Pharmaceutical Design (2017)

4. Predicting the Future: Phage Therapy, Egyptian Journal of Veterinary Science(Egypt) (2022)

5. Bacteriophages and Phage-Inspired Nanocarriers for Targeted Delivery of Therapeutic Cargos, Advanced Drug Delivery Reviews (2016)

6. Development and Clinical Application of Bispecific Antibody in the Treatment of Colorectal Cancer, Expert Review of Clinical Immunology (2020)

Experts (# of related papers)

Nima Rezaei (1)

Kobra Omidfar (1)

Style	Citing Format
MLA	Rahbarnia L, et al.. "Evolution of Phage Display Technology: From Discovery to Application." Journal of Drug Targeting, vol. 25, no. 3, 2017, pp. 216-224.
APA	Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Ahmadzadeh V, Akbari B (2017). Evolution of Phage Display Technology: From Discovery to Application. Journal of Drug Targeting, 25(3), 216-224.
Chicago	Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Ahmadzadeh V, Akbari B. "Evolution of Phage Display Technology: From Discovery to Application." Journal of Drug Targeting 25, no. 3 (2017): 216-224.
Harvard	Rahbarnia L et al. (2017) 'Evolution of Phage Display Technology: From Discovery to Application', Journal of Drug Targeting, 25(3), pp. 216-224.
Vancouver	Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Ahmadzadeh V, et al.. Evolution of Phage Display Technology: From Discovery to Application. Journal of Drug Targeting. 2017;25(3):216-224.
BibTex	@article{ author = {Rahbarnia L and Farajnia S and Babaei H and Majidi J and Veisi K and Ahmadzadeh V and Akbari B}, title = {Evolution of Phage Display Technology: From Discovery to Application}, journal = {Journal of Drug Targeting}, volume = {25}, number = {3}, pages = {216-224}, year = {2017} }
RIS	TY - JOUR AU - Rahbarnia L AU - Farajnia S AU - Babaei H AU - Majidi J AU - Veisi K AU - Ahmadzadeh V AU - Akbari B TI - Evolution of Phage Display Technology: From Discovery to Application JO - Journal of Drug Targeting VL - 25 IS - 3 SP - 216 EP - 224 PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract